Pregled bibliografske jedinice broj: 166227
Rofekoksib: djelotvornost u reumatoidnom artritisu i akutnoj boli
Rofekoksib: djelotvornost u reumatoidnom artritisu i akutnoj boli // Reumatizam, 50 (2003), 2; 47-48 (podatak o recenziji nije dostupan, članak, stručni)
CROSBI ID: 166227 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Rofekoksib: djelotvornost u reumatoidnom artritisu i akutnoj boli
(Rofecoxib: its efficacy in rheumatoid arthritis and acute pain)
Autori
Morović-Vergles, Jadranka
Izvornik
Reumatizam (0374-1338) 50
(2003), 2;
47-48
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
rofekoksib; reumatoidni artritis; akutna bol
(Rofecoxib; rheumatoid arthritis; acute pain)
Sažetak
Cyclooxygenase-II (cox-II) selective inhibitors and other non-steroidal anti-inflammatory drugs (NSAIDs) are indicated for pain and stiffness in inflammatory rheumatoid arthritis. Rofecoxib have been shown to be associated with a reduced incidence of gastric erosions on endoscopy compared to standard NSAIDs in patients with arthritis. Many studies in acute pain management have been performed with rofecoxib. The dental pain model is a typical study design of severe acute pain. Onset of pain relief occurred within 45 minutes in single-dose studies of rofecoxib 50 mg in postoperative dental pain. Rofecoxib consistently demonstrated analgesic efficacy in a variety of moderate to severe pain models.
Izvorni jezik
Hrvatski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- Index Medicus